ArticleJournal of gastrointestinal oncology2026

Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.

Lujun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.